Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1957 1
1961 2
1964 2
1965 3
1966 2
1967 2
1968 1
1969 4
1970 8
1971 10
1972 4
1973 2
1974 7
1975 2
1976 2
1978 3
1979 1
1980 2
1981 4
1982 5
1983 7
1984 1
1985 2
1986 7
1987 8
1988 6
1989 4
1990 4
1991 3
1992 7
1993 10
1994 9
1995 20
1996 12
1997 8
1998 5
1999 10
2000 7
2001 9
2002 4
2003 8
2004 7
2005 9
2006 7
2007 1
2008 5
2009 4
2010 5
2011 5
2012 7
2013 7
2014 11
2015 11
2016 4
2017 7
2018 11
2019 14
2020 28
2021 21
2022 21
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

383 results
Results by year
Filters applied: . Clear all
Page 1
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group. Ogo T, et al. Among authors: sugano t. Eur Respir J. 2022 Jul 7;60(1):2101694. doi: 10.1183/13993003.01694-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34824052 Free PMC article. Clinical Trial.
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.
Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, Kobayashi Y, Muramatsu T, Ishii H, Kozuma K, Tanaka N, Matsuo H, Uemura S, Kadota K, Hikichi Y, Tsujita K, Ako J, Nakagawa Y, Morino Y, Hamanaka I, Shiode N, Shite J, Honye J, Matsubara T, Kawai K, Igarashi Y, Okamura A, Ogawa T, Shibata Y, Tsuji T, Yajima J, Iwabuchi K, Komatsu N, Sugano T, Yamaki M, Yamada S, Hirase H, Miyashita Y, Yoshimachi F, Kobayashi M, Aoki J, Oda H, Katahira Y, Ueda K, Nishino M, Nakao K, Michishita I, Ueno T, Inohara T, Kohsaka S, Ismail TF, Serruys PW, Nakamura M, Yokoi H, Ikari Y; Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Cardiovascular Interventional Therapeutics (CVIT). Ozaki Y, et al. Among authors: sugano t. Cardiovasc Interv Ther. 2022 Jan;37(1):1-34. doi: 10.1007/s12928-021-00829-9. Epub 2022 Jan 12. Cardiovasc Interv Ther. 2022. PMID: 35018605 Free PMC article. Review.
[Ovarian cancer: TC therapy].
Sugano T, Katsumata N. Sugano T, et al. Nihon Rinsho. 2015 Feb;73 Suppl 2:604-8. Nihon Rinsho. 2015. PMID: 25831831 Japanese. No abstract available.
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma.
Takahashi A, Noro R, Takano N, Hisakane K, Takahashi S, Fukuizumi A, Omori M, Sugano T, Takeuchi S, Nakamichi S, Miyanaga A, Minegishi Y, Kubota K, Seike M, Gemma A. Takahashi A, et al. Among authors: sugano t. Mol Clin Oncol. 2022 Apr;16(4):87. doi: 10.3892/mco.2022.2520. Epub 2022 Feb 21. Mol Clin Oncol. 2022. PMID: 35251638 Free PMC article.
PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Hisakane K, Seike M, Sugano T, Matsuda K, Kunugi S, Nakamichi S, Matsumoto M, Miyanaga A, Noro R, Minegishi Y, Kubota K, Gemma A. Hisakane K, et al. Among authors: sugano t. Anticancer Res. 2021 May;41(5):2501-2509. doi: 10.21873/anticanres.15028. Anticancer Res. 2021. PMID: 33952478
Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Soga Y, Tsubakimoto Y, Yokoi H, Miyamoto A, Nakamura M. Yamauchi Y, et al. Among authors: sugano t. Circ Cardiovasc Interv. 2020 Aug;13(8):e009168. doi: 10.1161/CIRCINTERVENTIONS.120.009168. Epub 2020 Jul 29. Circ Cardiovasc Interv. 2020. PMID: 32755323 No abstract available.
One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y, Takahara M, Shintani Y, Iida O, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Hirano K, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators. Yamauchi Y, et al. Among authors: sugano t. Circ Cardiovasc Interv. 2019 Jan;12(1):e007441. doi: 10.1161/CIRCINTERVENTIONS.118.007441. Circ Cardiovasc Interv. 2019. PMID: 30616363 No abstract available.
383 results